 MD News (press release) |
Combination therapies pushing up costs without benefits in mild asthmatics
Pharma Times More costly combination therapies are significantly over-used in US patients with mild asthma, despite the lack of any apparent clinical benefit and despite … Mild Asthma – Most Medications Waste of Money, Report Reveals New Study: Overuse of Combination Drug Therapy in Patients with Mild Asthma … ICS/LABA combination therapy increases asthma-related pharmacy cost |
View full post on asthma – Google News